Applied DNA-CLEARED4 collaboration for pooled Covid-19 surveillance testing programme

30 December 2020 (Last Updated December 30th, 2020 07:43)

Applied DNA Clinical Laboratories (ADCL), a wholly-owned subsidiary of Applied DNA Sciences, has entered into a reseller and sales referral partnership with US-based health safety solutions provider CLEARED4.

Applied DNA-CLEARED4 collaboration for pooled Covid-19 surveillance testing programme
safeCircle can deliver results with the help of RT-PCR testing in 24 hours. Credit: Belova59 from Pixabay.

Applied DNA Clinical Laboratories (ADCL), a wholly-owned subsidiary of Applied DNA Sciences, has entered into a reseller and sales referral partnership with US-based health safety solutions provider CLEARED4.

According to the terms of the deal, ADCL can resell subscriptions to CLEARED4’s platform as part of the former’s safeCircle pooled Covid-19 surveillance testing programme.

In addition, CLEARED4 can refer its customers seeking pooled Covid-19 surveillance testing to ADCL.
ADCL’s safeCircle laboratory testing operations have been integrated with CLEARED4’s return-to-work health safety platform for ADCL customers as a value-added option.

safeCircle puts into use frequent, high-sensitivity pooled testing in a bid to prevent the Covid-19 spread by rapidly detecting infections within a community, workplace or school.

It can deliver results with the help of real-time PCR (RT-PCR) testing in 24 hours.

Applied DNA president and CEO Dr James Hayward said: “Partnering with CLEARED4 aligns with our growth expectations for the safeCircle platform and is especially functional for scaling high-volume clients.

“Identifying potential infections early and in a cost-efficient and rapid manner is how pooled
surveillance testing gets workers back to work, students back to school, and communities to reopen.”

Furthermore, ADCL’s pooled surveillance testing solution has been integrated into CLEARED4’s HIPAA-compliant platform as well and can offer safeCircle to its present and probable clients to augment their Covid-19 safety protocols.

Cleared4 and Chelsea Health Solutions CEO Dr Soumi Eachempati said: “The partnership between Applied DNA and CLEARED4 offers an unmatched level of Covid-19 risk mitigation and management to schools and businesses.

“CLEARED4’s medically-based software platform has already yielded over one million access passes.”

With this deal, ADCL will be able to deliver novel platform management features, such as automating the management and clients’ surveillance testing programme, monitoring as well as ensuring prompt communication of testing programme results, and quarantine compliance.

The Suffolk County Government in the US, an ADCL’s safeCircle client, is using CLEARED4 to deal with the reporting of the testing for its personnel.